Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

The Effects of Preoperative Aspirin on Graft Patency and Cardiac Events in Off-pump Coronary Artery Bypass

The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2010 by Chinese Academy of Medical Sciences, Fuwai Hospital.
Recruitment status was  Recruiting
Information provided by:
Chinese Academy of Medical Sciences, Fuwai Hospital Identifier:
First received: December 29, 2010
Last updated: December 30, 2010
Last verified: March 2010
Antiplatelet therapy is critical in the management of coronary artery disease.For patients undergoing off-pump coronary artery bypass graft,controversy remains regarding the safety of preoperative antiplatelet therapy.And there is little study about the effect of continuing aspirin until the surgery day on graft patency.So we would like to perform this study to evaluate the effects of preoperative aspirin on graft patency and cardiac events in off-pump coronary bypass.

Condition Intervention Phase
Coronary Artery Disease
Off-pump Coronary Artery Bypass
Drug: aspirin
Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment

Resource links provided by NLM:

Further study details as provided by Chinese Academy of Medical Sciences, Fuwai Hospital:

Primary Outcome Measures:
  • graft patency examined by CT scan [ Time Frame: one week after surgery ] [ Designated as safety issue: No ]
    we would like to compare the graft patency within the one week after the surgery between the preoperative aspirin use and preoperative nonuse.We just want to know wether preoperative aspirin use could improve the graft patency in off-pump coronary artery bypass.

Secondary Outcome Measures:
  • Bleeding, transfusion, re-exploration [ Time Frame: perioperative ] [ Designated as safety issue: Yes ]

Estimated Enrollment: 200
Study Start Date: March 2010
Estimated Primary Completion Date: March 2011 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: preoperative aspirin use Drug: aspirin
aspirin 100mg daily until the surgery day
No Intervention: preoperative aspirin nonuse Drug: aspirin
aspirin is stopped 5-7 days before operation


Ages Eligible for Study:   18 Years to 85 Years   (Adult, Senior)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Patients undergoing elective, off-pump coronary artery bypass with at least two grafts
  • patient able to give informed consent

Exclusion Criteria:

  • on-pump CABG
  • combined with the valve surgery
  • Preoperative use of clopidogrel and warfarin
  • allergy to aspirin
  • History of severe liver disease
  • History of bleeding diathesis,significant GI bleed
  • Patient has known renal failure or contraindication for Cardiac CT Angio
  • Redo CABG
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01268917

Fuwai Hospital Recruiting
Beijing, China, 100037
Contact: Hengchao Wu, MD    8601088398701   
Principal Investigator: Hansong Sun, MD         
Sponsors and Collaborators
Chinese Academy of Medical Sciences, Fuwai Hospital
  More Information

Responsible Party: Fuwai Hospital Identifier: NCT01268917     History of Changes
Other Study ID Numbers: Fuwai Hospital 2010-259 
Study First Received: December 29, 2010
Last Updated: December 30, 2010
Health Authority: China: Food and Drug Administration
China: Ethics Committee

Keywords provided by Chinese Academy of Medical Sciences, Fuwai Hospital:
coronary artery disease
off-pump coronary artery bypass

Additional relevant MeSH terms:
Coronary Artery Disease
Myocardial Ischemia
Coronary Disease
Heart Diseases
Cardiovascular Diseases
Arterial Occlusive Diseases
Vascular Diseases
Anti-Inflammatory Agents, Non-Steroidal
Analgesics, Non-Narcotic
Sensory System Agents
Peripheral Nervous System Agents
Physiological Effects of Drugs
Anti-Inflammatory Agents
Antirheumatic Agents
Fibrinolytic Agents
Fibrin Modulating Agents
Molecular Mechanisms of Pharmacological Action
Platelet Aggregation Inhibitors
Cyclooxygenase Inhibitors
Enzyme Inhibitors
Antipyretics processed this record on October 21, 2016